U.S. Capital Markets Stock News

NYSE:TRV
NYSE:TRVInsurance

Is Travelers Companies (TRV) Still Attractive After Strong Multi Year Share Price Gains

If you are wondering whether Travelers Companies at around US$306 per share still offers reasonable value, you are not alone. This article is designed to help you weigh what the current price might be implying. The stock has been relatively steady in the very short term with a 0.8% decline over the last 7 days, while the 30 day, year to date and 1 year returns of 3.8%, 7.4% and 20.8% give a fuller picture of how the market has been pricing it recently. Alongside these moves, investors have...
NYSE:D
NYSE:DIntegrated Utilities

What Dominion Energy (D)'s Data Center Spending Surge and 2026 Outlook Means For Shareholders

In February 2026, Dominion Energy reported past fourth-quarter 2025 sales of US$4,093 million and net income of US$567 million, alongside full-year 2025 sales of US$16.51 billion and net income of US$3.00 billion, and issued 2026 operating earnings guidance of US$3.45–US$3.69 per share. An important angle for investors is Dominion’s decision to significantly lift its 2026–2030 capital spending to US$64.70 billion to meet surging, data center-driven electricity demand from major technology...
NasdaqGS:NXST
NasdaqGS:NXSTMedia

A Look At Nexstar Media Group (NXST) Valuation After Recent Share Price Strength

Nexstar Media Group (NXST) shares have quietly moved higher over the past 3 months, with the stock up about 31% and roughly 16% over the past month, prompting closer attention from investors. See our latest analysis for Nexstar Media Group. Those recent gains sit within a stronger backdrop, with an 18.6% year to date share price return and a 44.6% total shareholder return over the past year, hinting at improving sentiment despite some short term pullbacks. If Nexstar’s move has you thinking...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Reassessing Atlassian (TEAM) After Sharp Share Price Pullback and Cash Flow Outlook

If you have been wondering whether Atlassian is starting to look attractively priced or still expensive, this article walks through what the current share price might actually imply. At a last close of US$83.62, the stock has had a mixed run, with an 11.3% gain over the past week but declines of 20.4% over 30 days, 46.0% year to date, and 65.0% over the past year, as well as 46.3% over 3 years and 63.5% over 5 years. Recent coverage around Atlassian has focused on how collaboration and...
NasdaqGS:PYPL
NasdaqGS:PYPLDiversified Financial

PayPal Weighs Index Exit, Partnerships And M&A Rumors Against Valuation

PayPal Holdings (NasdaqGS:PYPL) is scheduled to be removed from the S&P 100 index, a move that may affect its visibility with some institutional and index-linked investors. The company is continuing to build its digital payments ecosystem through new partnerships and technology integrations. At the same time, ongoing M&A rumors involving Stripe are drawing attention to external interest in PayPal's position in online payments. PayPal sits at the center of ecommerce and digital payments,...
NYSE:LOMA
NYSE:LOMABasic Materials

Is Loma Negra (LOMA) Quietly Recasting Its Risk Profile With Sustainability-Linked Debt Financing?

In the past week, Loma Negra held a board meeting to call an ordinary shareholders’ meeting for April 23, 2026, while also reporting a 22% cut in CO2 emissions since 2021 and issuing a new US$60,000,000 Class VI bond at a 6.5% interest rate. Together, the decarbonization progress and successful bond placement highlight how Loma Negra is tying its funding plans to longer-term sustainability objectives. We’ll now examine how Loma Negra’s successful US$60,000,000 bond issuance could influence...
NasdaqGS:WSBC
NasdaqGS:WSBCBanks

Is WesBanco (WSBC) Attractively Priced After Recent Share Price Weakness?

Wondering if WesBanco is actually good value at around its recent US$33.68 share price, or if the market is missing something? This article walks through what the numbers say about the stock. The share price sits at US$33.68 after a 3.4% decline over the last 7 days and a 9.6% decline over the last 30 days, while the 1 year return is 9.3% and the 3 year return is 18.9%. These moves come as investors continue to reassess US regional banks, with WesBanco often mentioned in broader sector...
NasdaqCM:LMB
NasdaqCM:LMBConstruction

Limbach Relocation To Tampa Highlights Push Into Mission Critical Verticals

Limbach Holdings (NasdaqCM:LMB) is relocating its corporate headquarters to Tampa, Florida in its 125th anniversary year. The company is aligning its senior leadership and a growing share of its workforce around the Tampa area. The move accompanies ongoing acquisitions and a sharpened focus on national vertical markets, including healthcare, data centers, and industrial manufacturing. Limbach Holdings operates as a building systems solutions provider, with services that span mechanical,...
NasdaqGM:AUPH
NasdaqGM:AUPHBiotechs

Aurinia Pharmaceuticals Earnings Strength And Valuation Gap Attract Investor Attention

Aurinia Pharmaceuticals reported four consecutive quarters of positive earnings surprises alongside improved profitability. Recent updates highlight strong sales performance and higher operating margins, supported by a solid financial position. The company, listed as NasdaqGM:AUPH, continues to show resilience within a competitive pharmaceutical sector. Aurinia Pharmaceuticals, trading on NasdaqGM:AUPH, is drawing attention after a run of four straight positive earnings surprises paired...
NasdaqCM:RIOT
NasdaqCM:RIOTSoftware

Riot Platforms Recasts Bitcoin Mining Story With AMD Rockdale Data Center Deal

Riot Platforms has acquired full ownership of its Rockdale data center campus, removing future rent obligations. The company has signed a 10 year data center lease with AMD, positioning Rockdale as an anchor facility for high performance computing and AI workloads. This marks a pivot for NasdaqCM:RIOT from being focused mainly on Bitcoin mining to operating as a broader digital infrastructure and data center provider. For investors who know Riot Platforms mainly as a Bitcoin miner, this...
NasdaqGS:PCAR
NasdaqGS:PCARMachinery

How Investors May Respond To PACCAR (PCAR) Record 2025 Results Amid Lagging Share Performance

PACCAR Inc recently reported strong 2025 results, with its Parts and Financial Services divisions delivering record performance across its global truck, parts, and financing operations. Despite this strength and declining short interest compared with peers, the stock has lagged broader industrial names such as Caterpillar, highlighting a gap between operational performance and market sentiment. Against this backdrop of record divisional results and cautious analyst optimism, we'll explore...
NasdaqCM:CPRX
NasdaqCM:CPRXBiotechs

Why Catalyst Pharmaceuticals (CPRX) Is Up 5.0% After Raising Its 2026 Revenue Outlook And What’s Next

In late February 2026, Catalyst Pharmaceuticals reported fourth quarter 2025 revenue of US$152.61 million and full-year 2025 revenue of US$588.99 million, alongside earnings guidance for full-year 2026 of US$615 million to US$645 million. These results highlight how expanding rare-disease franchises like FIRDAPSE and AGAMREE are becoming increasingly important profit drivers for the company. We’ll now examine how Catalyst’s raised 2026 revenue outlook reshapes its existing investment...
NYSE:KMT
NYSE:KMTMachinery

Assessing Kennametal (KMT) Valuation After Recent Momentum Cooldown

Kennametal overview and recent share performance Kennametal (KMT) has drawn fresh investor attention after recent share price moves, with the stock showing mixed short term returns and stronger results over the past 3 months and year to date. Over the past week, the share price return was about 7% lower, following a 1 day move of roughly 7% lower. Over the past month, the stock return was about 3% lower, while the past 3 months show a gain of roughly 33%. Year to date, Kennametal has returned...
NasdaqGS:FTNT
NasdaqGS:FTNTSoftware

Fortinet Q4 Beat And SASE Momentum Reshape 2026 Growth Story

Fortinet reported strong Q4 results that were ahead of expectations on both revenue and earnings. The company outlined an upbeat billings outlook for fiscal 2026 that is above prior consensus views. Management highlighted growing momentum in Fortinet’s Secure Access Service Edge, or SASE, offerings as a key driver. Fortinet, listed as NasdaqGS:FTNT, is drawing fresh attention after its latest quarterly update, which put a spotlight on both its core security franchise and its growing SASE...
NasdaqGS:IDYA
NasdaqGS:IDYABiotechs

IDEAYA Biosciences (IDYA) Valuation Check As Phase 1 IDE034 Trial Marks Key Pipeline Milestone

IDEAYA Biosciences (IDYA) is in focus after enrolling the first patient in a Phase 1 trial for IDE034, a bispecific TOP1 antibody drug conjugate targeting tumors with co expressed B7H3 and PTK7 antigens. See our latest analysis for IDEAYA Biosciences. The IDE034 trial and recent senior R&D hire come after a mixed year for the US$33.19 share price, with recent weakness contrasting with a strong 1 year total shareholder return of 79.79% that points to earlier, stronger momentum. If this kind of...
NasdaqGS:TEM
NasdaqGS:TEMLife Sciences

Is Tempus AI (TEM) Pricing Reflect Its AI Healthcare Ambitions After Recent Share Pullback

If you are wondering whether Tempus AI's share price reflects its underlying worth, you are not alone. Many investors are asking the same question as the story around this stock matures. Tempus AI recently closed at US$52.26, with returns of a 1.9% decline over 7 days, a 2.4% decline over 30 days and a 16.2% decline year to date, set against a 6.4% gain over the past year. Recent coverage has focused on Tempus AI's position in applying AI tools to healthcare decision making and how that...
NYSE:SHO
NYSE:SHOHotel and Resort REITs

A Look At Sunstone Hotel Investors (SHO) Valuation As Mixed Returns Stir Interest

Assessing recent performance for Sunstone Hotel Investors (SHO) Sunstone Hotel Investors (SHO) has been drawing attention after a recent share price of US$9.38, prompting investors to weigh its mixed return profile and current fundamentals before deciding how it might fit into a portfolio. See our latest analysis for Sunstone Hotel Investors. Recent trading has been choppy, with a 1 day share price return of a 2.09% decline contrasted by a 90 day share price return of 5.04%, while the 1 year...
NYSE:AZZ
NYSE:AZZBuilding

Assessing AZZ (AZZ) After A 39% Year Return And Recent Pullback

If you are wondering whether AZZ is still fairly priced after its recent run, this article will help you unpack what the current share price might be implying about the company. The stock closed at US$124.03, with returns of 13.0% year to date and 38.7% over the past year, although the last 7 days and 30 days saw declines of 8.8% and 2.0% respectively. Recent coverage has focused on AZZ as a capital goods player that some investors track for its role in industrial infrastructure. This helps...
NasdaqGS:TBLA
NasdaqGS:TBLAInteractive Media and Services

How Taboola’s Turn to Profit, 2026 Guidance and ESOP Plans At Taboola.com (TBLA) Has Changed Its Investment Story

In late February 2026, Taboola.com Ltd. reported past fourth-quarter 2025 revenue of US$522.31 million and net income of US$50.14 million, issued 2026 revenue guidance of US$444 million to US$462 million for the first quarter and US$1.99 billion to US$2.05 billion for the full year, and filed a US$23.20 million ESOP-related shelf registration for 7,389,921 ordinary shares. The shift from a full-year 2024 net loss to a 2025 net profit, alongside fresh revenue guidance and upcoming conference...
NYSE:VVX
NYSE:VVXAerospace & Defense

Assessing V2X (VVX) Valuation After Strong 2025 Results And Upbeat 2026 Revenue Guidance

V2X (VVX) is back in focus after reporting full year 2025 results and issuing fresh 2026 revenue guidance, giving investors new numbers to assess its defense focused mission support business. See our latest analysis for V2X. The earnings and 2026 revenue guidance arrived alongside strong price momentum, with a 30 day share price return of 11.71% and a 90 day gain of 31.25%. The 1 year total shareholder return of 55.33% suggests recent enthusiasm has been building rather than fading. If this...
NYSE:ENR
NYSE:ENRHousehold Products

Energizer Holdings Sell Off Puts Dividend Strength And Debt In Focus

Energizer Holdings (NYSE:ENR) is under pressure following a sector wide sell off in consumer staples. The move is linked to rising geopolitical tensions and renewed inflation concerns affecting equity markets. Investors are reassessing near term risk for battery and household product makers as volatility increases. Energizer Holdings, known for its batteries and household products, is getting fresh attention as consumer staples stocks react to macro headlines. With geopolitical tensions in...
NYSE:USPH
NYSE:USPHHealthcare

U.S. Physical Therapy Weighs CFO Exit Against New 10 Year Hospital Alliance

U.S. Physical Therapy (NYSE:USPH) announced that CFO Carey Hendrickson plans to resign, with an interim successor already designated. The company also disclosed a new 10 year hospital alliance that will integrate ten existing clinics into a hospital clinical services network. Both the executive change and hospital agreement are presented as material developments for the company’s operations and governance. U.S. Physical Therapy, which operates outpatient physical and occupational therapy...
NYSE:OGS
NYSE:OGSGas Utilities

Did ONE Gas' (OGS) New Equity Programs Quietly Redefine Its Capital Markets Playbook?

In late February 2026, ONE Gas, Inc. filed a US$225,000,000 at-the-market follow-on common stock offering and a US$41.21 million shelf registration tied to its dividend reinvestment plan. These equity moves, together with management’s appearance at multiple investor conferences, highlight ONE Gas’s focus on funding needs and deepening engagement with the capital markets. Next, we’ll examine how ONE Gas’s at-the-market equity issuance plans could influence its existing investment narrative...
NasdaqGS:MDGL
NasdaqGS:MDGLBiotechs

Is Madrigal Pharmaceuticals (MDGL) Pricing Reflect Long Term Potential After Recent Share Price Declines

If you are wondering whether Madrigal Pharmaceuticals' current share price reflects its potential, you are not alone. This article will focus squarely on what the numbers say about value. The stock closed at US$432.83, with returns of 0.2% over the past week, a 9.6% decline over 30 days, a 27.1% decline year to date, a 30.6% return over 1 year and a 79.1% return over 3 years, alongside a very large 5-year gain of around 3.7x. These mixed recent returns have come as investors absorb ongoing...